Laleh Kamalian
- Hepatology top 10%
- Liver physiology and pathology 2
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection 3
- Pharmacogenetics and Drug Metabolism 2
-
- Metabolism and Genetic Disorders 3
-
- Mitochondrial Function and Pathology 3
- Metabolomics and Mass Spectrometry Studies 2
- RNA modifications and cancer 1
-
- Cancer Mechanisms and Therapy 1
- Co-authors
- Amy E. ChadwickJan SnoeysB. Kevin ParkMario MonshouwerMark BaylissNeil FrenchJohn R. GosneyRobert Jones
- Journals
- Clinical Cancer Research (1 paper)Toxicology and Applied Pharmacology (1 paper)Toxicological Sciences (1 paper)
- Partner nations
- United KingdomBelgiumUnited States
In The Last Decade
Laleh Kamalian
8 papers receiving 330 citations
Peers
Comparison fields: 5 of 76
- Hepatology 81
- Pharmacology 80
- Clinical Biochemistry 30
- Cancer Research 42
- Molecular Biology 164
Countries citing papers authored by Laleh Kamalian
This map shows the geographic impact of Laleh Kamalian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laleh Kamalian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laleh Kamalian more than expected).
Fields of papers citing papers by Laleh Kamalian
This network shows the impact of papers produced by Laleh Kamalian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laleh Kamalian. The network helps show where Laleh Kamalian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laleh Kamalian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 8 | |
| 2 | 2019 | 12 | |
| 3 | 2018 | 35 | |
| 4 | 2016 | 22 | |
| 5 | 2016 | 95 | |
| 6 | 2015 | 116 | |
| 7 | 2012 | 1 | |
| 8 | 2008 | 44 | |
| 9 | [The experimental and clinical antitumor action of the interferon inducer larifan]. | 1991 | 0 |
About Laleh Kamalian
Laleh Kamalian is a scholar working on Pharmacology, Clinical Biochemistry and Hepatology, having authored 9 papers that have together received 333 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (3 papers), Metabolism and Genetic Disorders (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Liver physiology and pathology (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), RNA modifications and cancer (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Hepatology (81 citations), Pharmacology (80 citations) and Clinical Biochemistry (30 citations). Laleh Kamalian has collaborated with scholars based in United Kingdom, Belgium and United States. Frequent co-authors include Amy E. Chadwick, Jan Snoeys, B. Kevin Park, Mario Monshouwer, Mark Bayliss, Neil French, B. Kevin Park, John R. Gosney, Robert Jones and Hassan Malik. Their work appears in journals such as Clinical Cancer Research, Toxicology and Applied Pharmacology and Toxicological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.